BNP Paribas Arbitrage SA raised its position in shares of Arcturus Therapeutics by 63.4% during the second quarter.

Source: https://www.etfdailynews.com/2023/03/18/arcturus-therapeutics-nasdaqarct-coverage-initiated-by-analysts-at-stocknews-com/

Ensign Peak Advisors Inc grew its stake in Arcturus Therapeutics by 420.2% during the 2nd quarter.

Source: https://www.americanbankingnews.com/2023/04/03/arcturus-therapeutics-holdings-inc-nasdaqarct-sees-large-increase-in-short-interest.html

Hennion & Walsh Asset Management Inc. grew its holdings in shares of Arcturus Therapeutics by 11.7% in the fourth quarter.

Source: https://www.americanbankingnews.com/2023/04/03/arcturus-therapeutics-holdings-inc-nasdaqarct-sees-large-increase-in-short-interest.html

In synthesizing the multifaceted narrative of Arcturus Therapeutics, one cannot overlook the forward momentum the company carries.

Source: https://seekingalpha.com/article/4613660-arcturus-therapeutics-a-beacon-of-hope-for-rare-diseases-amid-the-mrna-race?source=feed_all_articles